These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 23092412)
1. Statin treatment and carotid plaque composition: a review of clinical studies. Puato M; Zambon A; Faggin E; Rattazzi M; Pauletto P Curr Vasc Pharmacol; 2014 May; 12(3):518-26. PubMed ID: 23092412 [TBL] [Abstract][Full Text] [Related]
2. Statin/ezetimibe combination therapy vs statin monotherapy for carotid atherosclerotic plaque inflammation. Oh M; Kim H; Shin EW; Sung C; Kim DH; Moon DH; Lee JS; Lee PH; Lee SW; Lee CW Medicine (Baltimore); 2021 Mar; 100(10):e25114. PubMed ID: 33725908 [TBL] [Abstract][Full Text] [Related]
3. The effect of statins on carotid plaque morphology: a LDL-associated action or one more pleiotropic effect of statins? Makris GC; Lavida A; Nicolaides AN; Geroulakos G Atherosclerosis; 2010 Nov; 213(1):8-20. PubMed ID: 20494361 [TBL] [Abstract][Full Text] [Related]
4. A new approach of statin therapy in carotid atherosclerosis: Targeting indices of plaque vulnerability on the top of lipid-lowering. A narrative review. Kadoglou NP; Khattab E; Velidakis N; Patsourakos N; Lambadiari V Kardiol Pol; 2022; 80(9):880-890. PubMed ID: 35734817 [TBL] [Abstract][Full Text] [Related]
5. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting. Cziraky MJ; Watson KE; Talbert RL J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279 [TBL] [Abstract][Full Text] [Related]
6. New LDL-cholesterol lowering therapies: pharmacology, clinical trials, and relevance to acute coronary syndromes. Sahebkar A; Watts GF Clin Ther; 2013 Aug; 35(8):1082-98. PubMed ID: 23932550 [TBL] [Abstract][Full Text] [Related]
7. Statin-induced microRNAome alterations modulating inflammation pathways of peripheral blood mononuclear cells in patients with hypercholesterolemia. Lin HJ; Yu SL; Su TC; Hsu HC; Chen MF; Lee YT; Chien KL; Lu TP Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32885808 [TBL] [Abstract][Full Text] [Related]
8. Cardiovascular risk reduction: what do recent trials with rosuvastatin tell us? Fabbri G; Maggioni AP Adv Ther; 2009 May; 26(5):469-87. PubMed ID: 19444394 [TBL] [Abstract][Full Text] [Related]
9. Are Patients with Low Non-HDL Cholesterol "Non-responders" to Statin Therapy on Coronary Plaque Regression? Koba S J Atheroscler Thromb; 2016 Sep; 23(9):1030-2. PubMed ID: 27397478 [No Abstract] [Full Text] [Related]
10. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments. Evans M; Roberts A; Davies S; Rees A Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326 [TBL] [Abstract][Full Text] [Related]
11. Comparison of statin eligibility according to the Adult Treatment Panel III, ACC/AHA blood cholesterol guideline, and presence of carotid plaque by ultrasound in Mexican mestizo patients with rheumatoid arthritis. Galarza-Delgado DA; Azpiri-Lopez JR; Colunga-Pedraza IJ; Cardenas-de la Garza JA; Vera-Pineda R; Garcia-Colunga JI; Arvizu-Rivera RI; Martinez-Moreno A; Villarreal-Perez JZ; Elizondo-Riojas G; Garza Elizondo MA Clin Rheumatol; 2016 Nov; 35(11):2823-2827. PubMed ID: 27222044 [TBL] [Abstract][Full Text] [Related]
12. Statin use is associated with carotid plaque composition: The Rotterdam Study. Mujaj B; Bos D; Selwaness M; Leening MJG; Kavousi M; Wentzel JJ; van der Lugt A; Hofman A; Stricker BH; Vernooij MW; Franco OH Int J Cardiol; 2018 Jun; 260():213-218. PubMed ID: 29519676 [TBL] [Abstract][Full Text] [Related]
14. Plaque microstructures in patients with coronary artery disease who achieved very low low-density lipoprotein cholesterol levels. Kataoka Y; Hammadah M; Puri R; Duggal B; Uno K; Kapadia SR; Murat Tuzcu E; Nissen SE; Nicholls SJ Atherosclerosis; 2015 Oct; 242(2):490-5. PubMed ID: 26298740 [TBL] [Abstract][Full Text] [Related]
15. 2017 Taiwan lipid guidelines for high risk patients. Li YH; Ueng KC; Jeng JS; Charng MJ; Lin TH; Chien KL; Wang CY; Chao TH; Liu PY; Su CH; Chien SC; Liou CW; Tang SC; Lee CC; Yu TY; Chen JW; Wu CC; Yeh HI; J Formos Med Assoc; 2017 Apr; 116(4):217-248. PubMed ID: 28242176 [TBL] [Abstract][Full Text] [Related]
16. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol. Tani S; Nagao K; Hirayama A Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320 [TBL] [Abstract][Full Text] [Related]
17. Management of Hypercholesterolemia, Appropriateness of Therapeutic Approaches and New Drugs in Patients with High Cardiovascular Risk. Agabiti Rosei E; Salvetti M High Blood Press Cardiovasc Prev; 2016 Sep; 23(3):217-30. PubMed ID: 27567901 [TBL] [Abstract][Full Text] [Related]
18. Aggressive lipid therapy in the statin era. Farmer JA Prog Cardiovasc Dis; 1998; 41(2):71-94. PubMed ID: 9790411 [TBL] [Abstract][Full Text] [Related]